ANL Adlai Nortye | 9/8/2026 | Reiterated Rating | $15.62 | $20.00 | Buy | $0.00 00.00% ROI | |
SVA Sinovac Biotech | 9/8/2026 | Reiterated Rating | $6.47 | $1.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 8/31/2026 | Reiterated Rating | $72.09 | $140.00 | Buy | $0.00 00.00% ROI | |
PDSB PDS Biotechnology | 8/26/2026 | Reiterated Rating | $0.22 | | Buy | $0.00 00.00% ROI | |
ANAB AnaptysBio | 8/24/2026 | Reiterated Rating | $56.98 | $95.00 | Buy | $0.00 00.00% ROI | |
BCDA BioCardia | 8/24/2026 | Reiterated Rating | $1.00 | | Buy | $0.00 00.00% ROI | |
CLNN Clene | 8/17/2026 | Reiterated Rating | $4.14 | | Buy | $0.00 00.00% ROI | |
OABI OmniAb | 8/17/2026 | Reiterated Rating | $3.93 | $11.00 | Buy | $0.00 00.00% ROI | |
RIGL Rigel Pharmaceuticals | 8/14/2026 | Reiterated Rating | $41.66 | $85.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 8/14/2026 | Reiterated Rating | $73.45 | | Buy | $0.00 00.00% ROI | |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
STTK Shattuck Labs | 8/11/2026 | Lower Price Target | $7.23 | $14.00 | Buy | $0.00 00.00% ROI | |
LGND Ligand Pharmaceuticals | 8/6/2026 | Boost Price Target | $312.13 | $358.00 | Buy | $0.00 00.00% ROI | |
QTTB Q32 Bio | 7/28/2026 | Boost Price Target | $15.21 | $36.00 | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 7/27/2026 | Reiterated Rating | $7.00 | | Neutral | $0.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 7/14/2026 | Reiterated Rating | $1.22 | | Buy | $0.00 00.00% ROI | |
NVCT Nuvectis Pharma | 6/22/2026 | Boost Price Target | $13.80 | $39.00 | Buy | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 6/16/2026 | Boost Price Target | $322.09 | $361.00 | Buy | $0.00 00.00% ROI | |
CLDX Celldex Therapeutics | 6/15/2026 | Reiterated Rating | $31.27 | $42.00 | Buy | $0.00 00.00% ROI | |
NVCT Nuvectis Pharma | 6/12/2026 | Boost Price Target | $10.67 | $13.00 | Buy | $0.00 00.00% ROI | |
ANAB AnaptysBio | 6/10/2026 | Initiated Coverage | $51.63 | $95.00 | Buy | $0.00 00.00% ROI | |
BCDA BioCardia | 6/9/2026 | Reiterated Rating | $0.92 | $25.00 | Buy | $0.00 00.00% ROI | |
STTK Shattuck Labs | 6/8/2026 | Reiterated Rating | $4.93 | $18.00 | Buy | $0.00 00.00% ROI | |
GUTS Fractyl Health | 6/4/2026 | Reiterated Rating | $0.78 | $8.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 6/2/2026 | Boost Price Target | $43.12 | $67.00 | Buy | $0.00 00.00% ROI | |
RIGL Rigel Pharmaceuticals | 6/2/2026 | Reiterated Rating | $29.86 | $57.00 | Buy | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 6/1/2026 | Reiterated Rating | $309.03 | $310.00 | Buy | $0.00 00.00% ROI | |
RIGL Rigel Pharmaceuticals | 5/22/2026 | Reiterated Rating | $29.19 | $57.00 | Buy | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 5/18/2026 | Reiterated Rating | $306.29 | $310.00 | Buy | $0.00 00.00% ROI | |
PROK ProKidney | 5/18/2026 | Reiterated Rating | $1.63 | $12.00 | Buy | $0.00 00.00% ROI | |
LSTA Lisata Therapeutics | 5/15/2026 | Downgrade | $3.19 | | Neutral | $0.00 00.00% ROI | |
NEUP Neuphoria Therapeutics | 5/15/2026 | Downgrade | $4.74 | | Neutral | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 5/13/2026 | Reiterated Rating | $31.52 | $60.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 5/11/2026 | Boost Price Target | $76.91 | $140.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 5/5/2026 | Boost Price Target | $44.91 | $57.00 | Buy | $0.00 00.00% ROI | |
QTTB Q32 Bio | 5/5/2026 | Reiterated Rating | $5.00 | $13.00 | Buy | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 5/4/2026 | Reiterated Rating | $278.00 | $310.00 | Buy | $0.00 00.00% ROI | |
CLNN Clene | 5/4/2026 | Reiterated Rating | $6.71 | $31.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 5/1/2026 | Downgrade | $3.12 | $3.16 | Neutral | $0.00 00.00% ROI | |
XOMA XOMA Royalty | 4/30/2026 | Downgrade | $40.99 | $39.00 | Neutral | $0.00 00.00% ROI | |
LGND Ligand Pharmaceuticals | 4/30/2026 | Boost Price Target | $224.86 | $289.00 | Buy | $0.00 00.00% ROI | |
BlackRock and Vanguard already own THIS (Ad) Institutions own roughly 88 percent of an overlooked American oil and natural gas company. BlackRock holds 32 million shares worth about 716 million dollars, while Vanguard owns 48 million shares worth nearly 1.1 billion dollars.
The company generates approximately 3.2 billion dollars in operating income against a market value of only about 8 billion dollars, and it has signed a multi-year AI agreement with Palantir to improve equipment reliability and well performance. Click here to learn about this overlooked AI energy stock |
CMPX Compass Therapeutics | 4/27/2026 | Reiterated Rating | $1.92 | $24.00 | Buy | $0.00 00.00% ROI | |
GUTS Fractyl Health | 4/24/2026 | Reiterated Rating | $0.58 | $8.00 | Buy | $0.00 00.00% ROI | |
ANL Adlai Nortye | 4/20/2026 | Boost Price Target | $16.01 | $20.00 | Buy | $0.00 00.00% ROI | |
STTK Shattuck Labs | 4/20/2026 | Boost Price Target | $7.53 | $18.00 | Buy | $0.00 00.00% ROI | |
PDSB PDS Biotechnology | 4/15/2026 | Reiterated Rating | $1.29 | $15.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 4/14/2026 | Reiterated Rating | $30.70 | $47.00 | Buy | $0.00 00.00% ROI | |
LGND Ligand Pharmaceuticals | 4/14/2026 | Boost Price Target | $230.97 | $243.00 | Buy | $0.00 00.00% ROI | |
CVKD Cadrenal Therapeutics | 4/7/2026 | Lower Price Target | $4.35 | $13.00 | Buy | $0.00 00.00% ROI | |
APRE Aprea Therapeutics | 3/31/2026 | Lower Price Target | $0.74 | $1.20 | Buy | $0.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 3/24/2026 | Reiterated Rating | $1.44 | $9.00 | Buy | $0.00 00.00% ROI | |
PHAR Pharming Group | 3/24/2026 | Reiterated Rating | $16.08 | $37.00 | Buy | $0.00 00.00% ROI | |
VKTX Viking Therapeutics | 3/23/2026 | Reiterated Rating | $32.33 | $102.00 | Buy | $0.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 3/23/2026 | Reiterated Rating | $1.63 | $6.00 | Buy | $0.00 00.00% ROI | |
XOMA XOMA Royalty | 3/20/2026 | Reiterated Rating | $28.76 | $97.00 | Buy | $0.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 3/12/2026 | Set Price Target | $1.70 | $6.00 | | $0.00 00.00% ROI | |
PHAR Pharming Group | 3/12/2026 | Set Price Target | $15.64 | $37.00 | Buy | $0.00 00.00% ROI | |
QTTB Q32 Bio | 3/10/2026 | Reiterated Rating | $6.01 | $13.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 3/10/2026 | Reiterated Rating | $2.73 | | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 3/10/2026 | Reiterated Rating | $35.61 | $60.00 | Buy | $0.00 00.00% ROI | |
PHGE BiomX | 3/9/2026 | Downgrade | $7.10 | | Hold | $0.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 3/6/2026 | Reiterated Rating | $1.91 | | Buy | $0.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 3/5/2026 | Boost Price Target | $1.68 | $6.00 | Buy | $0.00 00.00% ROI | |
QTTB Q32 Bio | 2/25/2026 | Initiated Coverage | $4.50 | $13.00 | Buy | $0.00 00.00% ROI | |
LGND Ligand Pharmaceuticals | 2/24/2026 | Boost Price Target | $189.97 | $239.00 | Buy | $0.00 00.00% ROI | |
FBIO Fortress Biotech | 2/23/2026 | Reiterated Rating | $3.66 | $17.00 | Buy | $0.00 00.00% ROI | |
ARMP Armata Pharmaceuticals | 2/23/2026 | Boost Price Target | $9.25 | $15.00 | Buy | $0.00 00.00% ROI | |
NAMS NewAmsterdam Pharma | 2/19/2026 | Upgrade | $34.63 | | Strong-Buy | $0.00 00.00% ROI | |
ANL Adlai Nortye | 2/13/2026 | Upgrade | $9.64 | $16.00 | Buy | $0.00 00.00% ROI | |
APRE Aprea Therapeutics | 1/29/2026 | Reiterated Rating | $0.58 | $4.00 | Buy | $0.00 00.00% ROI | |
CALC CalciMedica | 1/29/2026 | Reiterated Rating | $1.25 | | Neutral | $0.00 00.00% ROI | |
KURA Kura Oncology | 1/13/2026 | Reiterated Rating | $9.17 | $40.00 | Buy | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 1/9/2026 | Reiterated Rating | $248.91 | $310.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 12/22/2025 | Boost Price Target | $62.72 | $136.00 | Buy | $0.00 00.00% ROI | |
APRE Aprea Therapeutics | 12/18/2025 | Lower Price Target | $0.92 | $5.00 | Buy | $0.00 00.00% ROI | |
PROK ProKidney | 12/16/2025 | Initiated Coverage | $2.08 | $12.00 | Buy | $0.00 00.00% ROI | |
PROK ProKidney | 12/16/2025 | Initiated Coverage | $2.20 | $12.00 | Buy | $0.00 00.00% ROI | |
TNYA Tenaya Therapeutics | 12/12/2025 | Lower Price Target | $0.79 | $3.00 | Buy | $0.00 00.00% ROI | |
XOMA XOMA Royalty | 12/11/2025 | Lower Price Target | $26.13 | $97.00 | Buy | $0.00 00.00% ROI | |
NEUP Neuphoria Therapeutics | 12/5/2025 | Lower Price Target | $4.27 | $7.00 | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 12/3/2025 | Boost Price Target | $27.67 | $60.00 | Buy | $0.00 00.00% ROI | |
NVCT Nuvectis Pharma | 12/3/2025 | Reiterated Rating | $5.81 | | Buy | $0.00 00.00% ROI | |
GUTS Fractyl Health | 12/2/2025 | Reiterated Rating | $1.48 | $8.00 | Buy | $0.00 00.00% ROI | |
STTK Shattuck Labs | 12/1/2025 | Upgrade | $2.06 | $6.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 11/28/2025 | Reiterated Rating | $36.26 | $47.00 | Buy | $0.00 00.00% ROI | |
PHGE BiomX | 11/25/2025 | Boost Price Target | $2.90 | $260.00 | Buy | $0.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 11/24/2025 | Reiterated Rating | $1.75 | $9.00 | Buy | $0.00 00.00% ROI | |
KURA Kura Oncology | 11/14/2025 | Reiterated Rating | $10.68 | $40.00 | Buy | $0.00 00.00% ROI | |
PDSB PDS Biotechnology | 11/13/2025 | Boost Price Target | $0.85 | $15.00 | Buy | $0.00 00.00% ROI | |
LGND Ligand Pharmaceuticals | 11/6/2025 | Boost Price Target | $208.50 | $231.00 | Buy | $0.00 00.00% ROI | |
FTH Sensei Biotherapeutics | 10/30/2025 | Downgrade | $10.06 | | Neutral | $0.00 00.00% ROI | |
Do this before December or regret it (Ad) Porter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monetary reset tied to executive order 14241 - one he says could draw a sharp dividing line between prepared investors and those left behind.
The last time America reset its money - under Nixon in the 1970s - it produced an average of 1,300 new millionaires per day for over 50 years. Stansberry's new documentary names a core group of assets he believes are positioned to surge as Trump's new dollar rolls out.
Watch Porter Stansberry's full briefing and get his three steps to prepare before December. Watch Porter Stansberry's full briefing and get his three steps to prepare before December. |
IOVA Iovance Biotherapeutics | 10/29/2025 | Lower Price Target | $2.07 | $9.00 | Buy | $0.00 00.00% ROI | |
NAMS NewAmsterdam Pharma | 10/20/2025 | Initiated Coverage | $36.40 | $52.00 | Buy | $0.00 00.00% ROI | |
KURA Kura Oncology | 10/20/2025 | Reiterated Rating | $9.84 | $40.00 | Buy | $0.00 00.00% ROI | |
NAMS NewAmsterdam Pharma | 10/20/2025 | Initiated Coverage | $37.66 | $52.00 | Buy | $0.00 00.00% ROI | |
ATXS Astria Therapeutics | 10/16/2025 | Downgrade | $11.92 | | Hold | $0.00 00.00% ROI | |
RIGL Rigel Pharmaceuticals | 10/8/2025 | Reiterated Rating | $27.36 | $57.00 | Buy | $0.00 00.00% ROI | |
KURA Kura Oncology | 9/30/2025 | Reiterated Rating | $8.97 | $40.00 | Buy | $0.00 00.00% ROI | |
VKTX Viking Therapeutics | 9/29/2025 | Reiterated Rating | $25.65 | $102.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 9/29/2025 | Reiterated Rating | $52.79 | $120.00 | Buy | $0.00 00.00% ROI | |
GUTS Fractyl Health | 9/26/2025 | Lower Price Target | $1.32 | $8.00 | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 9/25/2025 | Reiterated Rating | $6.47 | $24.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 9/22/2025 | Reiterated Rating | $48.66 | $120.00 | Buy | $0.00 00.00% ROI | |
BCDA BioCardia | 9/22/2025 | Reiterated Rating | $1.13 | $25.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 9/19/2025 | Reiterated Rating | $24.19 | $47.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 9/19/2025 | Reiterated Rating | $2.75 | $16.00 | Buy | $0.00 00.00% ROI | |
ATXS Astria Therapeutics | 9/17/2025 | Boost Price Target | $7.76 | $20.00 | Buy | $0.00 00.00% ROI | |
GUTS Fractyl Health | 9/15/2025 | Initiated Coverage | $1.02 | $9.00 | Buy | $0.00 00.00% ROI | |
ATYR aTyr Pharma | 9/15/2025 | Downgrade | $1.12 | | Neutral | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 9/15/2025 | Reiterated Rating | $153.21 | $240.00 | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 9/11/2025 | Reiterated Rating | $6.30 | $24.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 9/10/2025 | Reiterated Rating | $27.53 | $47.00 | Buy | $00.00 00.00% ROI | |
TVTX Travere Therapeutics | 9/3/2025 | Reiterated Rating | $19.40 | $47.00 | Buy | $00.00 00.00% ROI | |
TNYA Tenaya Therapeutics | 9/2/2025 | Reiterated Rating | $1.13 | $5.00 | Buy | $0.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 9/2/2025 | Reiterated Rating | $1.11 | $4.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 8/28/2025 | Boost Price Target | $17.44 | $47.00 | Buy | $00.00 00.00% ROI | |
LGND Ligand Pharmaceuticals | 8/28/2025 | Boost Price Target | $160.51 | $206.00 | Buy | $000.00 00.00% ROI | |
TNYA Tenaya Therapeutics | 8/27/2025 | Reiterated Rating | $1.08 | $5.00 | Buy | $0.00 00.00% ROI | |
NEUP Neuphoria Therapeutics | 8/26/2025 | Reiterated Rating | $7.40 | $21.00 | Buy | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 8/22/2025 | Reiterated Rating | $145.70 | $240.00 | Buy | $000.00 00.00% ROI | |
LSTA Lisata Therapeutics | 8/21/2025 | Reiterated Rating | $2.40 | $15.00 | Buy | $0.00 00.00% ROI | |
FBIO Fortress Biotech | 8/21/2025 | Lower Price Target | $2.05 | $17.00 | Buy | $0.00 00.00% ROI | |
CLDX Celldex Therapeutics | 8/20/2025 | Lower Price Target | $24.02 | $42.00 | Buy | $00.00 00.00% ROI | |
PHGE BiomX | 8/20/2025 | Reiterated Rating | $104.12 | $2,850.00 | Buy | $0.00 00.00% ROI | |
IOVA Iovance Biotherapeutics | 8/19/2025 | Reiterated Rating | $2.50 | $20.00 | Buy | $0.00 00.00% ROI | |
VKTX Viking Therapeutics | 8/19/2025 | Reiterated Rating | $23.90 | $102.00 | Buy | $00.00 00.00% ROI | |
ATXS Astria Therapeutics | 8/13/2025 | Reiterated Rating | $6.65 | $16.00 | Buy | $0.00 00.00% ROI | |
FTH Sensei Biotherapeutics | 8/5/2025 | Reiterated Rating | $8.20 | $30.00 | Buy | $00.00 00.00% ROI | |
NVCT Nuvectis Pharma | 8/4/2025 | Lower Price Target | $7.01 | $10.00 | Buy | $00.00 00.00% ROI | |
YARW Yarrow Bioscience | 7/30/2025 | Downgrade | $0.39 | | Neutral | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 7/25/2025 | Reiterated Rating | $150.00 | $240.00 | Buy | $000.00 00.00% ROI | |
CAPR Capricor Therapeutics | 7/11/2025 | Lower Price Target | $7.94 | $24.00 | Buy | $00.00 00.00% ROI | |
PDSB PDS Biotechnology | 7/1/2025 | Reiterated Rating | $1.33 | $13.00 | Buy | $0.00 00.00% ROI | |
EWTX Edgewise Therapeutics | 6/30/2025 | Initiated Coverage | $13.17 | $42.00 | Buy | $00.00 00.00% ROI | |
VKTX Viking Therapeutics | 6/25/2025 | Reiterated Rating | $26.08 | $102.00 | Buy | $00.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 6/24/2025 | Reiterated Rating | $0.73 | $4.00 | Buy | $0.00 00.00% ROI | |
ATNM Actinium Pharmaceuticals | 6/24/2025 | Reiterated Rating | $1.52 | $4.00 | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 6/24/2025 | Reiterated Rating | $8.47 | $77.00 | Buy | $00.00 00.00% ROI | |
KRYS Krystal Biotech | 6/24/2025 | Reiterated Rating | $143.72 | $240.00 | Buy | $000.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 6/23/2025 | Reiterated Rating | $0.95 | $9.00 | Buy | $0.00 00.00% ROI | |
CDTX Cidara Therapeutics | 6/18/2025 | Upgrade | $22.10 | $41.00 | Buy | $0.00 00.00% ROI | |
Earth's biggest energy source: near Grand Canyon (Ad) The largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - and much of it sits beneath the desert near the Grand Canyon.
A drilling crew just hit the DOE's 2035 targets twelve years early, with costs down 50% in 18 months. Google signed on, Gates invested, and the Pentagon made it a priority. One company has been quietly building this infrastructure for sixty years. See the company sitting on the biggest energy source on Earth |
ESPR Esperion Therapeutics | 6/17/2025 | Reiterated Rating | $1.17 | $16.00 | Buy | $0.00 00.00% ROI | |
BLRX BioLineRx | 6/17/2025 | Reiterated Rating | $4.67 | | Buy | $0.00 00.00% ROI | |
CLDX Celldex Therapeutics | 6/13/2025 | Reiterated Rating | $20.35 | $50.00 | Buy | $00.00 00.00% ROI | |
CAPR Capricor Therapeutics | 6/13/2025 | Reiterated Rating | $12.51 | $77.00 | Buy | $00.00 00.00% ROI | |
ATXS Astria Therapeutics | 6/13/2025 | Reiterated Rating | $5.89 | $16.00 | Buy | $0.00 00.00% ROI | |
PDSB PDS Biotechnology | 6/11/2025 | Reiterated Rating | $1.68 | $13.00 | Buy | $0.00 00.00% ROI | |
MBRX Moleculin Biotech | 6/9/2025 | Upgrade | $16.75 | $100.00 | Buy | $0.00 00.00% ROI | |
PHIO Phio Pharmaceuticals | 6/5/2025 | Initiated Coverage | $2.10 | $14.00 | Buy | $0.00 00.00% ROI | |
ATYR aTyr Pharma | 6/4/2025 | Reiterated Rating | $5.32 | $35.00 | Buy | $0.00 00.00% ROI | |
ANL Adlai Nortye | 6/2/2025 | Downgrade | $1.57 | | Neutral | $00.00 00.00% ROI | |
BLRX BioLineRx | 5/28/2025 | Reiterated Rating | $3.68 | | Buy | $0.00 00.00% ROI | |
XOMA XOMA Royalty | 5/28/2025 | Reiterated Rating | $24.92 | $104.00 | Buy | $00.00 00.00% ROI | |
CRIS Curis | 5/19/2025 | Reiterated Rating | $40.60 | $340.00 | Buy | $0.00 00.00% ROI | |
ATYR aTyr Pharma | 5/19/2025 | Reiterated Rating | $3.27 | $35.00 | Buy | $0.00 00.00% ROI | |
ARMP Armata Pharmaceuticals | 5/19/2025 | Boost Price Target | $1.74 | $9.00 | Buy | $0.00 00.00% ROI | |
PHGE BiomX | 5/16/2025 | Lower Price Target | $107.10 | $2,850.00 | Buy | $0.00 00.00% ROI | |
CVKD Cadrenal Therapeutics | 5/16/2025 | Reiterated Rating | $15.14 | $32.00 | Buy | $0.00 00.00% ROI | |
CALC CalciMedica | 5/15/2025 | Reiterated Rating | $9.57 | $80.00 | Buy | $0.00 00.00% ROI | |
ATNM Actinium Pharmaceuticals | 5/12/2025 | Reiterated Rating | $1.55 | $4.00 | Buy | $0.00 00.00% ROI | |
IOVA Iovance Biotherapeutics | 5/9/2025 | Lower Price Target | $3.17 | $20.00 | Buy | $0.00 00.00% ROI | |
ITRM Iterum Therapeutics | 5/8/2025 | Reiterated Rating | $0.92 | $9.00 | Buy | $0.00 00.00% ROI | |
BMEA Biomea Fusion | 5/6/2025 | Lower Price Target | $2.00 | $18.00 | Buy | $0.00 00.00% ROI | |
CLDX Celldex Therapeutics | 5/6/2025 | Reiterated Rating | $20.29 | $80.00 | Buy | $00.00 00.00% ROI | |
KRYS Krystal Biotech | 5/6/2025 | Reiterated Rating | $141.18 | $240.00 | Buy | $000.00 00.00% ROI | |
NVCT Nuvectis Pharma | 4/30/2025 | Reiterated Rating | $10.33 | $15.00 | Buy | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 4/28/2025 | Boost Price Target | $167.35 | $240.00 | Buy | $000.00 00.00% ROI | |
KURA Kura Oncology | 4/28/2025 | Reiterated Rating | $6.41 | $40.00 | Buy | $0.00 00.00% ROI | |
ATNM Actinium Pharmaceuticals | 4/28/2025 | Reiterated Rating | $1.34 | $4.00 | Buy | $0.00 00.00% ROI | |
TNYA Tenaya Therapeutics | 4/25/2025 | Reiterated Rating | $0.46 | $5.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 4/25/2025 | Reiterated Rating | $0.88 | $16.00 | Buy | $0.00 00.00% ROI | |
YARW Yarrow Bioscience | 4/25/2025 | Lower Price Target | $69.50 | $225.00 | Buy | $00.00 00.00% ROI | |
VKTX Viking Therapeutics | 4/24/2025 | Reiterated Rating | $25.84 | $102.00 | Buy | $00.00 00.00% ROI | |
CMPX Compass Therapeutics | 4/21/2025 | Reiterated Rating | $1.78 | $24.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 4/21/2025 | Reiterated Rating | $38.01 | $120.00 | Buy | $00.00 00.00% ROI | |
VKTX Viking Therapeutics | 4/17/2025 | Reiterated Rating | $23.45 | $102.00 | Buy | $00.00 00.00% ROI | |
CYTK Cytokinetics | 4/15/2025 | Reiterated Rating | $39.07 | $120.00 | Buy | $00.00 00.00% ROI | |
TPST Tempest Therapeutics | 4/10/2025 | Reiterated Rating | $7.15 | $16.00 | Neutral | $0.00 00.00% ROI | |
XBIO Xenetic Biosciences | 4/9/2025 | Reiterated Rating | $2.38 | | Neutral | $0.00 00.00% ROI | |
CLNN Clene | 4/8/2025 | Reiterated Rating | $2.99 | $31.00 | Buy | $0.00 00.00% ROI | |
PHGE BiomX | 4/4/2025 | Reiterated Rating | $111.34 | $3,990.00 | Buy | $00.00 00.00% ROI | |
CMPX Compass Therapeutics | 4/4/2025 | Boost Price Target | $1.61 | $24.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 4/4/2025 | Reiterated Rating | $40.52 | $120.00 | Buy | $00.00 00.00% ROI | |
KAPA Kairos Pharma | 4/3/2025 | Initiated Coverage | $6.43 | $84.00 | Buy | $0.00 00.00% ROI | |
PHGE BiomX | 4/1/2025 | Boost Price Target | $105.58 | $3,990.00 | Buy | $00.00 00.00% ROI | |
CALC CalciMedica | 4/1/2025 | Reiterated Rating | $9.55 | $80.00 | Buy | $0.00 00.00% ROI | |
ATNM Actinium Pharmaceuticals | 4/1/2025 | Reiterated Rating | $1.61 | $4.00 | Buy | $0.00 00.00% ROI | |
BMEA Biomea Fusion | 3/31/2025 | Reiterated Rating | $2.30 | $40.00 | Buy | $0.00 00.00% ROI | |
TNYA Tenaya Therapeutics | 3/31/2025 | Reiterated Rating | $0.61 | $5.00 | Buy | $0.00 00.00% ROI | |
BLRX BioLineRx | 3/31/2025 | Boost Price Target | $3.03 | $26.00 | Buy | $0.00 00.00% ROI | |
XOMA XOMA Royalty | 3/28/2025 | Reiterated Rating | $20.97 | $104.00 | Buy | $00.00 00.00% ROI | |
They didn't warn anyone in 1971. This time someone is warning you. (Ad) On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade.
Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction.
A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free. Request the free guide in 30 seconds and get positioned now |
TPST Tempest Therapeutics | 3/28/2025 | Lower Price Target | $10.92 | $208.00 | Buy | $0.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 3/28/2025 | Reiterated Rating | $0.63 | $4.00 | Buy | $0.00 00.00% ROI | |
APTO Aptose Biosciences | 3/28/2025 | Boost Price Target | $3.33 | $6.00 | Buy | $0.00 00.00% ROI | |
PDSB PDS Biotechnology | 3/27/2025 | Lower Price Target | $1.25 | $13.00 | Buy | $0.00 00.00% ROI | |
VKTX Viking Therapeutics | 3/26/2025 | Reiterated Rating | $26.07 | $102.00 | Buy | $00.00 00.00% ROI | |
ATNM Actinium Pharmaceuticals | 3/25/2025 | Reiterated Rating | $1.73 | $4.00 | Buy | $0.00 00.00% ROI | |
BMEA Biomea Fusion | 3/24/2025 | Reiterated Rating | $2.87 | $40.00 | Buy | $0.00 00.00% ROI | |
CLNN Clene | 3/24/2025 | Reiterated Rating | $4.06 | $31.00 | Buy | $0.00 00.00% ROI | |
XBIO Xenetic Biosciences | 3/20/2025 | Reiterated Rating | $3.64 | | Neutral | $0.00 00.00% ROI | |
PHAR Pharming Group | 3/20/2025 | Reiterated Rating | $8.86 | $37.00 | Buy | $00.00 00.00% ROI | |
ESPR Esperion Therapeutics | 3/20/2025 | Reiterated Rating | $1.62 | $16.00 | Buy | $0.00 00.00% ROI | |
XOMA XOMA Royalty | 3/19/2025 | Reiterated Rating | $20.89 | $104.00 | Buy | $00.00 00.00% ROI | |
OABI OmniAb | 3/19/2025 | Reiterated Rating | $3.19 | $11.00 | Buy | $0.00 00.00% ROI | |
ATNM Actinium Pharmaceuticals | 3/18/2025 | Reiterated Rating | $1.24 | $4.00 | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 3/17/2025 | Reiterated Rating | $13.23 | $77.00 | Buy | $00.00 00.00% ROI | |
ATYR aTyr Pharma | 3/14/2025 | Reiterated Rating | $3.99 | $35.00 | Buy | $0.00 00.00% ROI | |
PHAR Pharming Group | 3/14/2025 | Reiterated Rating | $8.74 | $37.00 | Buy | $00.00 00.00% ROI | |
PDSB PDS Biotechnology | 3/13/2025 | Reiterated Rating | $1.27 | $21.00 | Buy | $0.00 00.00% ROI | |
CLNN Clene | 3/12/2025 | Reiterated Rating | $4.41 | $31.00 | Buy | $0.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 3/11/2025 | Reiterated Rating | $0.53 | $9.00 | Buy | $0.00 00.00% ROI | |
TNYA Tenaya Therapeutics | 3/11/2025 | Lower Price Target | $0.51 | $5.00 | Buy | $0.00 00.00% ROI | |
ATNM Actinium Pharmaceuticals | 3/11/2025 | Reiterated Rating | $1.12 | $4.00 | Buy | $0.00 00.00% ROI | |
VKTX Viking Therapeutics | 3/11/2025 | Reiterated Rating | $25.36 | $102.00 | Buy | $00.00 00.00% ROI | |
ATXS Astria Therapeutics | 3/11/2025 | Reiterated Rating | $5.91 | $16.00 | Buy | $0.00 00.00% ROI | |
PDSB PDS Biotechnology | 3/7/2025 | Reiterated Rating | $1.28 | $21.00 | Buy | $0.00 00.00% ROI | |
YARW Yarrow Bioscience | 3/6/2025 | Reiterated Rating | $115.50 | $287.50 | Buy | $00.00 00.00% ROI | |
RIGL Rigel Pharmaceuticals | 3/5/2025 | Reiterated Rating | $22.08 | $57.00 | Buy | $00.00 00.00% ROI | |
CALC CalciMedica | 3/4/2025 | Reiterated Rating | $11.00 | $80.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 3/4/2025 | Reiterated Rating | $1.76 | $16.00 | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 3/4/2025 | Reiterated Rating | $14.23 | $77.00 | Buy | $00.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 3/3/2025 | Reiterated Rating | $0.35 | $4.00 | Buy | $0.00 00.00% ROI | |
IOVA Iovance Biotherapeutics | 2/28/2025 | Reiterated Rating | $5.26 | $32.00 | Buy | $0.00 00.00% ROI | |
CLDX Celldex Therapeutics | 2/28/2025 | Reiterated Rating | $20.31 | $80.00 | Buy | $00.00 00.00% ROI | |
CYTK Cytokinetics | 2/28/2025 | Reiterated Rating | $47.45 | $120.00 | Buy | $00.00 00.00% ROI | |
KRYS Krystal Biotech | 2/28/2025 | Reiterated Rating | $176.56 | $221.00 | Buy | $000.00 00.00% ROI | |
KURA Kura Oncology | 2/27/2025 | Reiterated Rating | $7.77 | $40.00 | Buy | $0.00 00.00% ROI | |
ATXS Astria Therapeutics | 2/27/2025 | Reiterated Rating | $6.45 | $16.00 | Buy | $0.00 00.00% ROI | |
CLNN Clene | 2/25/2025 | Reiterated Rating | $4.33 | $31.00 | Buy | $0.00 00.00% ROI | |
NVCT Nuvectis Pharma | 2/25/2025 | Lower Price Target | $7.06 | $11.00 | Buy | $0.00 00.00% ROI | |
PDSB PDS Biotechnology | 2/24/2025 | Reiterated Rating | $1.23 | $21.00 | Buy | $0.00 00.00% ROI | |
YARW Yarrow Bioscience | 2/19/2025 | Reiterated Rating | $131.90 | $287.50 | Buy | $00.00 00.00% ROI | |
KRYS Krystal Biotech | 2/19/2025 | Reiterated Rating | $171.70 | $221.00 | Buy | $000.00 00.00% ROI | |
PTNT Palatin Technologies | 2/13/2025 | Lower Price Target | $54.25 | $350.00 | Buy | $0.00 00.00% ROI | |
APTO Aptose Biosciences | 2/12/2025 | Reiterated Rating | $6.70 | $60.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 2/11/2025 | Reiterated Rating | $1.86 | $16.00 | Buy | $0.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 2/11/2025 | Reiterated Rating | $0.64 | $9.00 | Buy | $0.00 00.00% ROI | |
PTNT Palatin Technologies | 2/7/2025 | Reiterated Rating | $49.50 | $850.00 | Buy | $0.00 00.00% ROI | |
KURA Kura Oncology | 2/6/2025 | Boost Price Target | $9.05 | $40.00 | Buy | $0.00 00.00% ROI | |
VKTX Viking Therapeutics | 2/6/2025 | Reiterated Rating | $33.50 | $102.00 | Buy | $00.00 00.00% ROI | |
NEUP Neuphoria Therapeutics | 2/4/2025 | Boost Price Target | $5.10 | $21.00 | Buy | $0.00 00.00% ROI | |
XOMA XOMA Royalty | 2/3/2025 | Lower Price Target | $26.61 | $104.00 | Buy | $00.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 1/31/2025 | Reiterated Rating | $0.63 | $9.00 | Buy | $0.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 1/29/2025 | Reiterated Rating | $0.93 | $4.00 | Buy | $0.00 00.00% ROI | |
PTNT Palatin Technologies | 1/28/2025 | Reiterated Rating | $46.50 | $850.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 1/23/2025 | Reiterated Rating | $2.20 | $16.00 | Buy | $0.00 00.00% ROI | |
ATXS Astria Therapeutics | 1/23/2025 | Reiterated Rating | $7.53 | $16.00 | Buy | $00.00 00.00% ROI | |
RIGL Rigel Pharmaceuticals | 1/22/2025 | Reiterated Rating | $21.29 | $57.00 | Buy | $00.00 00.00% ROI | |
CYTK Cytokinetics | 1/21/2025 | Reiterated Rating | $45.72 | $120.00 | Buy | $00.00 00.00% ROI | |
VKTX Viking Therapeutics | 1/17/2025 | Reiterated Rating | $33.66 | $102.00 | Buy | $00.00 00.00% ROI | |
APRE Aprea Therapeutics | 1/15/2025 | Reiterated Rating | $3.77 | $20.00 | Buy | $0.00 00.00% ROI | |
TNYA Tenaya Therapeutics | 1/14/2025 | Reiterated Rating | $1.50 | $18.00 | Buy | $0.00 00.00% ROI | |
RIGL Rigel Pharmaceuticals | 1/14/2025 | Reiterated Rating | $17.11 | $57.00 | Buy | $00.00 00.00% ROI | |
YARW Yarrow Bioscience | 1/14/2025 | Reiterated Rating | $151.00 | $287.50 | Buy | $00.00 00.00% ROI | |
BMEA Biomea Fusion | 1/14/2025 | Reiterated Rating | $4.15 | $40.00 | Buy | $0.00 00.00% ROI | |
ATXS Astria Therapeutics | 1/13/2025 | Reiterated Rating | $7.27 | $16.00 | Buy | $00.00 00.00% ROI | |
APTO Aptose Biosciences | 1/10/2025 | Reiterated Rating | $6.40 | $60.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 1/10/2025 | Reiterated Rating | $2.17 | | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 1/10/2025 | Reiterated Rating | $47.37 | $120.00 | Buy | $00.00 00.00% ROI | |
VKTX Viking Therapeutics | 1/8/2025 | Reiterated Rating | $41.52 | $102.00 | Buy | $00.00 00.00% ROI | |
CMPX Compass Therapeutics | 1/8/2025 | Reiterated Rating | $1.77 | $10.00 | Buy | $0.00 00.00% ROI | |
PHGE BiomX | 1/8/2025 | Reiterated Rating | $140.51 | $380.00 | Buy | $00.00 00.00% ROI | |
CYTK Cytokinetics | 10/17/2024 | Reiterated Rating | $55.28 | $120.00 | Buy | $00.00 00.00% ROI | |